VANTAS Drug Patent Profile
✉ Email this page to a colleague
When do Vantas patents expire, and what generic alternatives are available?
Vantas is a drug marketed by Endo Pharm and is included in one NDA.
The generic ingredient in VANTAS is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.
Summary for VANTAS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 4 |
Patent Applications: | 1,073 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VANTAS |
What excipients (inactive ingredients) are in VANTAS? | VANTAS excipients list |
DailyMed Link: | VANTAS at DailyMed |
Recent Clinical Trials for VANTAS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 3 |
Southwest Oncology Group | Phase 3 |
University of Colorado, Denver | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for VANTAS
US Patents and Regulatory Information for VANTAS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharm | VANTAS | histrelin acetate | IMPLANT;SUBCUTANEOUS | 021732-001 | Oct 12, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VANTAS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharm | VANTAS | histrelin acetate | IMPLANT;SUBCUTANEOUS | 021732-001 | Oct 12, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharm | VANTAS | histrelin acetate | IMPLANT;SUBCUTANEOUS | 021732-001 | Oct 12, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VANTAS
See the table below for patents covering VANTAS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 1018392 | ⤷ Try a Trial | |
Denmark | 0551698 | ⤷ Try a Trial | |
European Patent Office | 0551698 | Fabrication d'articles hydrophiles hydro-gonflables et dispositifs de délivrance de médicaments (Manufacture of water - swellable hydrophilic articles and drug delivery devices) | ⤷ Try a Trial |
Austria | 149345 | ⤷ Try a Trial | |
Denmark | 0551698 | ⤷ Try a Trial | |
Australia | 651654 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |